Status:
RECRUITING
Thulium Fiber Laser (TFL) vs Holmium MOSES for Treatment of Benign Prostatic Hyperplasia (BPH)
Lead Sponsor:
Thunder Bay Regional Health Research Institute
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
Benign prostatic hyperplasia (BPH), the non-cancerous enlargement of the prostate, places pressure on the urethra and causes urination and bladder problems. Transurethral Resection of the Prostate (TU...
Eligibility Criteria
Inclusion
- Males over 50 years of age at the time of enrollment
- Referred to urology for refractory LUTS or urinary retention secondary to BPH
- Failed medical (non-surgical) treatment
- Prostate size on preoperative TRUS of≥80 ml
- IPSS \>15 and QOL score ≥3 and Qmax \<15 ml/sec
- Written informed consent to participate in the study
- Ability to comply with the requirements of the study procedures
Exclusion
- Previous surgical treatment for BPH
- History of prostate cancer
- Prostate size \< 80 mL
- History of urethral stenosis or its management
- Known or suspected neurogenic bladder
- Participants with active urinary tract infection until appropriately treated
- Participants with preexisting conditions, which, in the opinion of the investigator, interfere with the conduct of the study
- Participants who lack the capacity, or cannot speak English, in order to provide free and informed written consent
Key Trial Info
Start Date :
April 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT05240001
Start Date
April 20 2022
End Date
December 1 2025
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, Canada, P7B 6V4